Eschbach, Germany

Ernst Küsters

This inventor holds 3 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernst Küsters. Retrieved from https://idiyas.com/inventor/ernst-kanduumlsters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ernst Küsters: Innovator in Fermentative Preparation Processes

Introduction

Ernst Küsters is a notable inventor based in Eschbach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of processes related to cytostatics. With a total of 3 patents, Küsters has established himself as a key figure in his area of expertise.

Latest Patents

Küsters' latest patents focus on macrolides and the fermentative preparation process for cytostatics. His inventions include a new process for concentrating epothilones in culture media, a novel method for the production of epothilones, and an innovative approach for separating epothilones A and B. Additionally, he has developed a new strain obtained by mutagenesis for the production of epothilones, along with new crystal forms of epothilone B.

Career Highlights

Ernst Küsters is currently associated with Novartis AG, a leading global healthcare company. His work has been instrumental in advancing the understanding and production of important pharmaceutical compounds. His expertise in biotechnology has led to significant advancements in the field.

Collaborations

Küsters has collaborated with notable colleagues such as Hans Hofmann and Marion Mahnke. These partnerships have contributed to the success of his research and innovations.

Conclusion

Ernst Küsters is a prominent inventor whose work in the field of biotechnology has led to valuable advancements in the production of cytostatics. His contributions continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…